Next Quarterly Earnings
Thursday, October 15, 2026
CW 42
Pre-Market
In 49 days
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Kuros Biosciences
Kuros Biosciences, headquartered in Switzerland, is a leading biopharmaceutical company specializing in innovative bone graft substitutes. By developing advanced technologies for orthopedic surgery, Kuros Biosciences is dedicated to optimizing bone healing processes and patient outcomes worldwide.
Frequently asked questions
When will Kuros Biosciences report its next quarterly earnings?
Kuros Biosciences is scheduled to report its next quarterly earnings on 10/15/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
When did Kuros Biosciences last report quarterly earnings?
Kuros Biosciences last reported quarterly earnings on 8/13/2026 (Q2 2026). Earnings per share (EPS) came in at 0.06 CHF.
How does Kuros Biosciences stock react to earnings?
Across its last 3 earnings reports, Kuros Biosciences stock moved by ±4.7% on average the following day. The largest reaction was +10.6% on 03/10/2026; 3 of 3 reactions were positive.
How do I add the Kuros Biosciences earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Stock reaction to earnings
±4.7%
Avg. next-day move
+10.6%
Largest move (03/10/2026)
100%
Share of positive reactions
±7.7%
Avg. move after 7 days
Basis: price reactions to the last 3 report dates (close to close).
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Kuros Biosciences
Country
More Financial Information